ID: ALA5269181

Chembl Id: CHEMBL5269181

Max Phase: Preclinical

Molecular Formula: C35H41F3N6O5S

Molecular Weight: 714.81

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(N)nc3c2ncn3C(=O)Nc2cccc(C(F)(F)F)c2)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C35H41F3N6O5S/c1-6-32(4)15-23(33(5)18(2)10-12-34(19(3)27(32)47)13-11-22(45)26(33)34)49-24(46)16-50-29-25-28(42-30(39)43-29)44(17-40-25)31(48)41-21-9-7-8-20(14-21)35(36,37)38/h6-9,14,17-19,23,26-27,47H,1,10-13,15-16H2,2-5H3,(H,41,48)(H2,39,42,43)/t18-,19+,23-,26?,27+,32-,33+,34+/m1/s1

Standard InChI Key:  XBPFUVJYTJNTHN-JATDXGTRSA-N

Alternative Forms

  1. Parent:

    ALA5269181

    ---

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 714.81Molecular Weight (Monoisotopic): 714.2811AlogP: 6.51#Rotatable Bonds: 6
Polar Surface Area: 162.32Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 13.79CX Basic pKa: 1.51CX LogP: 5.69CX LogD: 5.69
Aromatic Rings: 3Heavy Atoms: 50QED Weighted: 0.11Np Likeness Score: 0.32

References

1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y..  (2023)  Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.,  14  (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004]

Source